Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315393 · ClinicalTrials.gov registry record
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
A clinical trial of Microscopic Polyangiitis and Granulomatosis With Polyangiitis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,046
- Enrollment target
- 8
- Study locations
NCT00315393 is a study of Microscopic Polyangiitis and Granulomatosis With Polyangiitis that has completed, run by University of Pennsylvania. The registered enrollment target is 1,046 participants, above the 679-participant average among 4 other Microscopic Polyangiitis trials with a reported enrollment target (54% higher). The trial reports 8 study locations across 6 states.
The verdict
NCT00315393, a study of Microscopic Polyangiitis and Granulomatosis With Polyangiitis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,046 participants
- Enrollment target
- 8
- Study locations
Study Summary
Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA) are two rare immune system disorders that cause the inflammation of blood vessels, or vasculitis. In order to properly treat these diseases, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GPA or MPA.
Conditions Studied
Study Locations (8)
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- Mount Sinai Hospital - Toronto
Massachusetts
- Boston University School of Medicine - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic Foundation - Cleveland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,046 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315393
The ClinicalTrials.gov registry entry for NCT00315393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,046 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 679-participant average among 4 other Microscopic Polyangiitis trials with a reported enrollment target (54% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Microscopic Polyangiitis appearing as the primary indexed condition, and to 0 interventions.
NCT00315393 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Pennsylvania, Ontario, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00315393 about?
NCT00315393 is a clinical study titled "Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis". Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA) are two rare immune system disorders that cause the inflammation of blood vessels, or vasculitis. In order to properly treat these diseases, it is critical that the level of disease activity can be determined over ...
What is the current status of trial NCT00315393?
This trial is currently completed. The enrollment target is 1,046 participants. The study started on 2006-04. Estimated completion is 2019-12.
What conditions does trial NCT00315393 study?
This clinical trial studies the following conditions: Microscopic Polyangiitis, Granulomatosis With Polyangiitis, Wegener's.
Who is sponsoring clinical trial NCT00315393?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315393 being conducted?
This trial has 8 study locations across Massachusetts, Minnesota, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microscopic Polyangiitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Microscopic Polyangiitis
All registered trials for this condition
Granulomatosis With Polyangiitis
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.